Printer Friendly

WARNER-LAMBERT, GLAXO ANNOUNCE CONTRACT-SIGNING FOR OTC MARKETING

 MORRIS PLAINS, N.J., Dec. 13 /PRNewswire/ -- Warner-Lambert Company (NYSE: WLA) and Glaxo Holdings p.l.c. (NYSE: GLX) today said they have entered into a joint venture to develop, seek approval and market over- the-counter (OTC) versions of Glaxo prescription drugs, including the leading ulcer treatment product, Zantac. Zantac is the world's largest selling prescription medication, with sales exceeding $3 billion in 1993.
 The joint venture, first announced following the signing of a letter of intent last July, will concentrate initially on developing Zantac for sale as an OTC product in the U.S., and will be extended to other major markets outside the U.S., excluding Japan.
 Clinical studies are in progress evaluating Zantac's performance at doses lower than prescription levels, for the prevention and treatment of conditions such as episodic heartburn. The agreements include U.S. rights to the Zantac trademark for approved OTC claims and dosage forms, as well as the marketing of Rx-to-OTC switch candidates worldwide.
 Warner-Lambert and Glaxo will share development costs and profits equally, with Glaxo receiving a royalty on all OTC sales by the joint venture.
 Direction of the joint venture will be provided by a management committee of representatives from each company. Day-to-day operations will be the responsibility of Warner-Lambert, and the joint venture's OTC products will be sold by Warner-Lambert's consumer health care products sales and marketing organization.
 Warner-Lambert is a worldwide company devoted to discovering, developing, manufacturing and marketing quality health care and consumer products. It employs approximately 34,000.
 -0- 12/13/93
 /CONTACT: Peter Wolf, 201-540-6696, Lisa Wilder, 201-540-2145, or Sandy Horner, 201-540-4268 (media); and Stephen Mock, 201-540-6916, or Cary Rosansky, 201-540-4874 (investors), all of Warner-Lambert/
 (WLA GLX)


CO: Warner-Lambert Company; Glaxo Holdings p.l.c. ST: New Jersey IN: HEA SU: CON

SH -- NY042 -- 3081 12/13/93 10:10 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 13, 1993
Words:305
Previous Article:FEDERAL JUDGE MAKES CRIMINAL REFERRAL OF RAFI KHAN TO U.S. ATTORNEY; SCOTLAND YARD DETECTIVE TESTIFIED KHAN TO BE ARRESTED TODAY IN ENGLAND
Next Article:E&B MARINE APPLICATION FOR NASDAQ LISTING IS ACCEPTED; MAKES PRINCIPAL PAYMENT ON DEBT; ANNOUNCES STORE OPENING
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters